Neurotech Pharmaceuticals, Inc.
Jacob Patterson Esq. is currently the VP and Head of Quality at Neurotech Pharmaceuticals, Inc., with a strong background in quality management within the pharmaceutical industry. With previous experience at companies such as Catalent Pharma Solutions, Emergent BioSolutions, and GE Healthcare, Jacob has developed and implemented risk-based quality strategies, led global quality organizations, and managed quality operations for the manufacture of vaccines and biologics. Jacob is also a founding partner at Modern Law Group and holds degrees in law, regulatory affairs, corporate finance, political science, international relations, and history.
This person is not in any offices
Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients. Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.